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Abstract: We describe a tissue optics plug-in that interfaces with the
GEANT4/GAMOS Monte Carlo (MC) architecture, providing a means of
simulating radiation-induced light transport in biological media for the first
time. Specifically, we focus on the simulation of light transport due to the
Čerenkov effect (light emission from charged particle’s traveling faster than
the local speed of light in a given medium), a phenomenon which requires
accurate modeling of both the high energy particle and subsequent optical
photon transport, a dynamic coupled process that is not well-described by
any current MC framework. The results of validation simulations show
excellent agreement with currently employed biomedical optics MC codes,
[i.e., Monte Carlo for Multi-Layered media (MCML), Mesh-based Monte
Carlo (MMC), and diffusion theory], and examples relevant to recent
studies into detection of Čerenkov light from an external radiation beam or
radionuclide are presented. While the work presented within this paper
focuses on radiation-induced light transport, the core features and robust
flexibility of the plug-in modified package make it also extensible to more
conventional biomedical optics simulations. The plug-in, user guide,
example files, as well as the necessary files to reproduce the validation
simulations described within this paper are available online at
http://www.dartmouth.edu/optmed/research-projects/monte-carlo-software.
©2013 Optical Society of America
OCIS codes: (170.3660) Light propagation in tissues; (170.5280) Photon migration; (170.7050)
Turbid media.
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1. Introduction
A growing area of research within the field biomedical optics involves the use of radiationinduced light emission in biological media, and can be attributed to the Čerenkov effect, a
phenomena which results in broadband optical emission when a charged particle travels
through a dielectric medium at a speed greater than the local phase velocity of light [1,2]. To
date, the primary application of this light emission has been in Čerenkov luminescence
imaging (CLI), a novel imaging modality capable of non-invasively monitoring the kinetic
distribution of radionuclides in vivo [3–6]. Several studies have also proposed the extension

#184904 - $15.00 USD
Received 5 Feb 2013; revised 3 Apr 2013; accepted 9 Apr 2013; published 17 Apr 2013
(C) 2013 OSA 1 May 2013 | Vol. 4, No. 5 | DOI:10.1364/BOE.4.000741 | BIOMEDICAL OPTICS EXPRESS 743

of CLI to three-dimensional optical tomography [7–9]. A number of recent of studies have
also demonstrated the feasibility of collecting Čerenkov emission from a turbid medium that
is excited by an external radiation beam [10–13]. The Čerenkov radiation is predominately
emitted in the ultraviolet (UV) and blue wavebands due to an inverse square wavelength
dependence, and therefore several groups have investigated Čerenkov-induced fluorescence,
an approach which allows researchers to shift the inherent emission to the near-infrared (NIR)
wavelengths which are more favorable to light transport through biological tissue [10,14].
Conceptually, these measurements have the potential to impact clinical practice, as they could
be used to optically monitor and optimize radiation therapy treatments by providing noninvasive molecular information to the clinician. As these research directives are in their
relative infancy, it is necessary to develop and validate a simulation software package that can
be used to investigate the radiation-induced light transport in biological media.
Modeling of the Čerenkov light emission process in scattering media cannot be easily
described by analytical models of radiation transport (such as the diffusion approximation to
the RTE), and instead requires the use of stochastic Monte Carlo (MC) methods. Multiple
versions of publicly available MC codes exist that are often used to describe photon
propagation in turbid media for biomedical applications. Most publicly available MC
packages extend from the original work by Wang and Jacques on Monte Carlo for MultiLayered media (MCML), which simulates to photon propagation through layered tissue.
Later-generation packages evolved to consider time-resolution (tMCing), GPU-based
acceleration (MCX), and mesh-based grid construction (MMC) [15–18]. However, these
packages are not well suited to accurately consider all aspects of the generation and transport
of radiation-induced photons, which requires description of the of high-energy radiation
transport (i.e., either from an external beam or exogenous radionuclide), generation of the
subsequent Čerenkov photons, and propagation of the photons through the medium while
tracking photon interactions with scatterers, absorbers, and fluorophores. Customization of
the existing software codes to describe these processes, while possible, would require
substantial editing and subsequent re-validation.
The present paper presents a simulation package that is capable of accurately describing
all aspects of the Čerenkov process in turbid media. At the core of this package is the
Geometry and Tracking (GEANT4) software, which is an object-oriented toolkit for the
simulation of particle propagation through matter [19]. It utilizes a plethora of physics models
to simulate radiation transport of various particles through matter, has been extensively
validated, and has been utilized to describe transport in the areas of high-energy, nuclear,
space, and medical physics, among others [20–23]. Despite the power and vast simulation
capabilities of the GEANT4 architecture, the package is inherently difficult to use and
requires an extensive knowledge of C++ to design personalized simulations. However, the
GEANT4 architecture for medically oriented simulations (GAMOS) provides a framework
for users to easily interface with GEANT4 using only text-based scripts [24]. The GAMOS
project has reported almost one thousand registered users and has been validated by several
groups for various radiation-based applications [25,26]. In addition, while GEANT4 includes
a set of optical photon physics processes, to the best of the authors’ knowledge simulation of
diffuse light transport in GEANT4 has neither been fully characterized nor validated. The
need for an expanded tissue optics toolbox is suggested by a recent study that used GEANT4
for modeling Čerenkov radiation for medical applications (e.g. as in [27]), which did not
consider the light transport of the Čerenkov optical photons following generation; such
investigations would require rigorous and accurate handling of optical photon-tissue
interactions (e.g. absorption, scattering, fluorescence, etc.), and would allow studies to
consider the influence of optical properties on the observed optical remission.
The present paper presents the development of a tissue optics plug-in that interfaces with
the combined GEANT4/GAMOS architecture to extend new and enhanced capabilities for
users to simulate optical photon transport through turbid media. The resulting package allows
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users to easily simulate the stochastic transport of both the high-energy particles and
radiation-induced optical photons within biological media, while simultaneously allowing
users to take advantage of the many pre-existing features of GEANT4/GAMOS, (i.e., the
ability to specify advanced source detector distributions, generate complex heterogeneous
geometries, and record a wide range of data outputs). Therefore, the aims of this study are to:
(1) to describe a new tissue optics plug-in to the GEANT4/GAMOS package for radiationinduced light transport in biological media, (2) to validate the processes governing the optical
photon-medium interactions within the context of its intended applications, and (3) to provide
examples indicative of recently explored applications of the Čerenkov effect within the
medical context. The results presented in this paper demonstrate how the resulting tissue
optics modified GEANT4/GAMOS package may be of great use to, and extend beyond
radiation-induced light transport to more conventional biomedical optics simulations.
2. Tissue optics plug-in for GEANT4/GAMOS

Fig. 1. In (a) the relevant radiation processes used in radiation induced light propagation
modeling. Primary photons undergo interactions with the medium, resulting in charged
particles that emit optical photons via the Čerenkov process. In (b) the implemented optical
photon processes in the tissue optics plug-in for GEANT4/GAMOS are shown.

Modeling of radiation transport for biomedical research applications requires an advanced
simulation architecture due to the vast number of relevant physics processes. In addition,
analytical methods are not well suited for modeling such complex particle interactions, and
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therefore stochastic MC methods must be used. To date, several radiation transport software
packages have been developed solely for the determination of dose in radiation therapy (e.g.,
EGSnrc, BEAMnrc, MCNPX). On the other hand, GEANT4 represents an architecture
originally developed for high-energy particle physics simulations, with a secondary
application to medical physics-oriented simulations.
As such, of the available MC codes, GEANT4 is the only framework in which both the
radiation transport and optical Čerenkov process have been implemented, as historically the
Čerenkov effect has been utilized for a number of particle physics applications [28–33].
Therefore GEANT4 provides a unique setting for stochastically modeling and investigating
the emerging biomedical applications of the Čerenkov effect. The complexity of the
simulation scenario is depicted in Fig. 1, which highlights the relevant physics processes
necessary for the accurate simulation of the Čerenkov effect in biological media.
In Fig. 1(a), the relevant physics processes ultimately resulting in the generation of optical
photons via the Čerenkov effect for an incident x-ray photon within the medically relevant
energy range, (i.e., keV – MeV) is presented. Incident photons may undergo three primary
radiation interactions, Compton scattering (moderate energy), pair production (high energy),
and the photoelectric effect (low energy). Note, in Compton scattering the photon is only
scattered and may continue to propagate and undergo more radiation events, whereas in the
latter two processes the photon is terminated. All processes lead to the generation of a
secondary charged particle (in the case of pair production, both a positron and electron are
generated), which subsequently undergo a separate group of radiation processes. During
propagation (under the condition that the electron’s energy is greater than the minimum
threshold energy for Čerenkov radiation in the given medium, see [21]), optical photons are
continuously generated along the electrons incremental steps. Electrons may also undergo
electron scattering, liberating more secondary electrons, or the Bremsstrahlung process in
which additional x-ray photons are generated. In the case of positrons, the same physics
processes are encountered, in addition to annihilation in which two 0.511 MeV photons are
generated upon the positron annihilating with an electron.
The light transport physics utilized in the proposed tissue optics plug-in is shown in Fig.
1(b). The implemented physics processes represent modifications to pre-existing GEANT4
optical physics processes, as well as new processes, the details of which are summarized in
Table 1. Optical photons may undergo optical absorption (and subsequent remission via
fluorescence), scattering, and refraction or reflection. In the case of scattering, four scattering
models have been implemented, each with a different sampled phase function, P(θ,λ). These
include Rayleigh scattering, Mie scattering (in which the scattering phase function is based
upon the Henyey-Greenstein approximation and the spectral dependence is modulated by the
anisotropy, g(λ), a modification over the pre-existing GEANT4 Mie process which accepts
only a constant anisotropy for all wavelengths), Modified Henyey-Greenstein (MHG)
scattering (in which the scattering represents a proportional combination of Rayleigh and Mie
scattering components through α(λ), implemented as described in [34]), and a user-defined
scattering process (in which the wavelength-dependent scattering phase function is explicitly
defined by the user). This latter scattering process may be of use in cases where the diffusion
approximation is not valid [35].
An important feature of any optical MC code is the sampling of step sizes for optical
photon propagation [36]. The implementation in the GEANT4 architecture is as described
with detail in [37], the photon step size is sampled from an exponential distribution calculated
from the defined scattering coefficient, μs(λ), and optical absorption along the propagation
path is independently sampled from a distribution defined using the absorption coefficient,
μa(λ), with the absorption treated as a binary event (i.e., no photon packeting or partial photon
weight is implemented). The fluorescence process acts in a similar manner to the optical
absorption process, with a separate fluorescence absorption coefficient, μaf(λ), and
fluorescence emission spectrum, If(λ). In addition, the probability for fluorescent photon
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generation following absorption can be controlled through definition of the quantum yield, φ,
a feature not available in the pre-existing GEANT4 class, and the time profile of fluorescence
emission can be designated as a delta function or exponential distribution with a specified
lifetime, t.
Table 1. Implemented Tissue Optics Plug-in Classes
Class

Inheriting GEANT4

Inputs

New features

Absorption

G4OpAbsorption

μa(λ)

New units

Fluorescence

G4OpWLS

μaf(λ), If(λ), φ, t

New units, quantum yield

Rayleigh scattering

G4OpRayleigh

μs(λ)

New units

Mie scattering

G4OpMieHG

μs(λ), g(λ)

New units, spectral g(λ)

MHG scattering

N/A

μs(λ), g(λ), α(λ)

New process

User-defined scattering

N/A

μs(λ), P(θ,λ)

New process

Refraction/reflection

G4OpBoundaryProcess

n1(λ), n2(λ)

N/A

Uniform source distribution

N/A

S(λ)

New source type

User-defined source distribution

N/A

S(λ), SM

New source type

Fluence scorer

N/A

N/A

New class

Optical photon wavelength

N/A

N/A

New data type

Čerenkov effect

G4Cerenkov

SM

Fixed sampling

A change implemented in the tissue optics plug-in with respect to the pre-existing
GEANT4 physics processes is the handling of units. As a simulation architecture initially
designed for high-energy physics research, the global GEANT4 unit system is based on the
class library for high-energy physics (CLHEP), which operates on a predefined set of unit
classes. The implications of this are that for biomedical optics simulations, the attenuation
coefficients must be defined as attenuation lengths, and optical photon wavelengths must be
defined in terms of optical photon energy (i.e., eV). To improve the ease of use and
functionality of the GEANT4/GAMOS framework for biomedical optics simulations, the
tissue optics plug-in has enabled the use of inverse length and wavelength units for the
definition of attenuation coefficients and optical photon energies respectively. The flexibility
of the designed new unit system also facilities a multitude of unit prefixes, (i.e., a user can
define the inverse lengths as /mm, /cm, /um, and the optical photon wavelength as μm, nm,
pm, etc.). To compliment these unit changes, a new recordable data type has also been created
which allows users to record an optical photon’s wavelength, rather than energy.
In addition, one of the novelties of performing optical simulations using the
GEANT4/GAMOS tissue optics plug-in is the ability to easily perform broadband, white-light
simulations. Optical properties (e.g., μs, g, μa, n, etc.) are defined at discrete wavelengths, λ,
and initiated photons can be sampled from a user-defined source spectrum or uniform
wavelength distribution, S(λ), within a defined waveband. However, when performing a white
light simulation, the number of initiated photons necessary to converge to a statistically
relevant result increases proportionally. Therefore, in the tissue optics plug-in a modification
has been made to allow for two sampling methods, SM, in all photon generation methods
(i.e., source, fluorescence, and Čerenkov processes). These methods include continuous and
fixed sampling, where in the former, linear interpolation is used to continuously sample the
generation distributions, and in the latter, optical photons are only generated at discrete
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wavelengths corresponding to the wavelengths where the optical properties have been
defined. The latter method serves as a variance reduction technique, allowing for white light
simulations to be performed within a waveband and user-chosen spectral resolution.
Finally, although a number of pre-existing scoring mechanisms are currently available in
the GAMOS framework, none are equipped to record the spatial fluence distribution, a
parameter of interest to the biomedical optics community. Therefore an additional scoring
method has been created which effectively scores the fluence by summing and recording the
track length of each propagating photon’s step by the local absorption coefficient within a
given voxel. In voxels at the boundary of two differing materials, the scoring is performed
such that the step length in each material is treated separately, and each is divided by the
appropriate absorption coefficient before being scored in the given voxel.
3. Results
3.1 Validation simulations
To validate the optical physics of the tissue optics plug-in, we start by conducting a
simulation analogous to the validation of MCML by Wang et al. in which the total diffuse
reflectance, Rd, and total transmittance Td (including unscattered transmittance) are calculated
for a semi-infinite slab with the following optical properties: relative refractive index nrel =
1.0 (matched boundary condition), absorption coefficient μa = 10 cm−1, scattering coefficient
μs = 90 cm−1, anisotropy factor g = 0.75, and slab thickness d = 0.02 cm. To approximate a
semi-infinite medium the slab cross section was set to 10 x 10 cm2.
Ten Monte Carlo simulations were performed using 107 photons. The difference between
the calculated mean and the results from van de Hulst’s table, as well as results reported by
Prahl et al. and MCML are shown in Table 2 [18,38,39].
Table 2. Validation of the Total Diffuse Reflectance and Transmittance for a Matched
Boundary Condition Semi-infinite Slab to Results of van de Hulst’s Table, MCML, and
Prahl et al.
Source

Rd Average

Rd Error

Tt Average

Tt Error

van de Hulst, 1980

0.09739

0.66096

MCML, 1995

0.09734

0.00005

0.66096

0.00000

Prahl et al., 1989

0.09711

0.00028

0.66159

0.00063

GEANT4/GAMOS, 2013

0.09741

0.00002

0.66102

0.00006

For a mismatched boundary condition, we perform a similar simulation for a semi-infinite
slab with the following optical properties: nrel = 1.5 (mismatched boundary condition),
absorption coefficient μa = 10 cm−1, scattering coefficient μs = 90 cm−1, anisotropy factor g =
0 (isotropic scattering), and slab thickness d = 0.02 cm. To approximate a semi-infinite
medium the slab cross-section was set to 10 x 10 cm2. Ten Monte Carlo simulations were
performed using 107 photons, the results of which are presented in Table 3 in comparison to
results reported by MCML, Prahl et al., and Giovanelli [18,39,40].
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Table 3. Validation of the Total Diffuse Reflectance and Transmittance for a Mismatched
Boundary Condition Semi-infinite Slab to Results of Giovanelli, MCML, and Prahl et al.
Source

Rd Average

Rd Error

Giovanelli, 1955

0.26000

MCML, 1995

0.25907

0.00093

Prahl et al., 1989

0.26097

0.00097

GEANT4/GAMOS, 2013

0.25969

0.00031

We reproduce the validation used to verify the MCML package and use the
GEANT4/GAMOS tissue optics plug-in to compute the angularly resoled diffuse reflectance
and transmittance of a semi-infinite slab with the following optical properties: nrel = 1.0,
absorption coefficient μa = 10 cm−1, scattering coefficient μs = 90 cm−1, anisotropy factor g =
0.75, and slab thickness d = 0.02 cm. To approximate a semi-infinite medium the slab cross
section was set to 10 x 10 cm2. For the simulation, 108 photons were used and the global
coordinate system was set such that photons were launched in the –z direction, with the x-y
plane parallel to the semi-infinite medium surface. The pre-existing data recording
capabilities of GEANT4/GAMOS were used to record the directional cosines of each photon
emerging from the slab as either reflectance or transmittance (i.e., for a photon emerging with
a directional vector, v = v 1xˆ + v 2 yˆ + v 3 zˆ the values v 1 , v 2 and v 3 were recorded, where the
exit angle is defined as cos(θ ) = v 3 , where v 21 + v 2 2 + v 23 = 1 ). The results were used to
generate a histogram using 30 bins between 0 and 90 deg. and are compared to data from van
de Hulst’s table in Fig. 2. In addition to recording the diffuse transmittance, the unscattered
transmittance was also calculated and found to be 0.13534, in agreement with the
theoretically expected unscattered transmittance which is given by exp[-(μs + μa)d] = 0.13534
for the given optical properties.

Fig. 2. In (a) the angularly resolved diffuse reflectance, Rd(θ) is shown as a function of exit
angle in comparison to van de Hulst’s table. In (b) the diffuse transmittance, Td(θ) is plotted.

For comparison to MCML, we performed simulations and recorded the internal fluence in
the depth direction for a semi-infinite medium with a matched and mismatched refractive
index boundary condition for the following optical properties: nrel = 1.0 or 1.37, absorption
coefficient μa = 0.01 cm−1, scattering coefficient μs = 100 cm−1, and anisotropy factor g = 0.9.
The fluence was scored using 200 bins between 0 and 1 cm, and calculated by scoring the
average track length of photons traversing each voxel divided by the absorption coefficient of
the corresponding voxel. To avoid boundary effects at a depth of 1 cm, the depth of the actual
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medium was extended to 10 cm. In addition, to approximate a semi-infinite medium the
medium cross section was set to 10 x 10 cm2. The results are shown in Fig. 3 normalized to
those reported by MCML.

Fig. 3. The depth resolved fluence for a semi-infinite medium with a refractive index matched
(nrel = 1.0) and mismatched (nrel = 1.37) boundary are shown in comparison to results from
MCML.

To validate the time-resolving capabilities of the GEANT4/GAMOS tissue optics plug-in,
a simulation similar to Fang et al. was performed [16]. A 60 x 60 x 60 mm3 homogenous
domain with an origin located at the center of the domain was generated with a point source
located at (0,0,60) mm incident with an initial direction of (0,0,-1) and the following optical
properties: nrel = 1.0, absorption coefficient μa = 0.005 mm−1, scattering coefficient μs = 1
mm−1, and anisotropy factor g = 0.01. The entire cubic domain was split into 2 x 2 x 2 mm3
voxels, and the temporal fluence was recorded for the voxel with a centroid located at (0,16,20) mm by scoring the average track length of photons traversing the voxel by the
absorption coefficient of the voxel. Due to the pre-existing GEANT4/GAMOS data recording
capabilities, the temporal fluence was calculated by considering the initial global time that a
photon entered the voxel of interest.

Fig. 4. The temporal fluence for a homogenous cubic medium in comparison to the timedomain response function (TPSF) predicted by diffusion theory.

The resulting hits were used to generate a histogram of 50 bins between 0 and 5 ns. For
the simulation, 108 photons were used. The results are normalized and plotted in Fig. 4 in
comparison to the analytical expectation from diffusion theory.
To validate the accuracy of the GEANT4/GAMOS tissue optics plug-in in resolving 2D
fluence in a homogenous medium, a simulation was performed with an identical geometry to
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that used for the temporal resolved fluence with optical properties of: nrel = 1.0, absorption
coefficient μa = 0.005 mm−1, scattering coefficient μs = 1 mm−1, and anisotropy factor g =
0.01. However, in this case the fluence was recorded in a 30 x 30 grid of 2 x 2 x 2 mm3
voxels centered at y = 0 mm in the 60 x 60 x 60 mm3 homogenous medium domain. For the
simulation, 108 photons were simulated, and the fluence was calculated by scoring the
average track length of photons traversing the voxel by the absorption coefficient of the
voxel. The results are shown in Fig. 5(a) for contours produced at 10 dB spacing in
comparison to that of MMC [16].

Fig. 5. In (a) a comparison between the 2D fluence calculated by GEANT4/GAMOS and
MMC for a homogenous medium. In (b) the comparison between the 2D fluence calculated by
GEANT4/GAMOS and the fluence results returned by MMC for an identical inhomogeneous
medium. In both figures the contour lines are shown at 10 dB spacing.

To validate the accuracy of the GEANT4/GAMOS tissue optics plug-in in resolving 2D
fluence in an inhomogeneous medium, a simulation was performed with a similar geometry to
that used for the homogenous 2D fluence validation: nrel = 1.0, absorption coefficient μa =
0.002 mm−1, scattering coefficient μs = 1 mm−1, and anisotropy factor g = 0.01. However, a
spherical inclusion with a radius of 10 mm was centered inside the cubic medium with optical
properties: nrel = 1.0, absorption coefficient μa = 0.05 mm−1, scattering coefficient μs = 5
mm−1, and anisotropy factor g = 0.9. The fluence was recorded in a 30 x 30 grid of 2 x 2 x 2
mm3 voxels centered at y = 0 mm in the 60 x 60 x 60 mm3 homogenous medium domain. For
the simulation, 108 photons were simulated, and the fluence was calculated by scoring the
average track length of photons traversing the voxel by the absorption coefficient of the
voxel. The results are shown in Fig. 5(b) for contours produced at 10 dB spacing in
comparison to that of MMC [16].
3.2 Example radiation induced optical simulations
To demonstrate the flexibility of the GEANT4/GAMOS tissue optics plug-in in simulating
radiation-induced light transport in biological media, two example simulations were
performed. Each was designed to mimic relevant scenarios involving the practical utilization
of optical photons generated by the Čerenkov effect.
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Fig. 6. In (a) and (b) the simulation geometry for the external radiation beam scenario. In (c)
and (d) the simulation geometry for the PET agent scenario.

In the first scenario, optical photons are generated by a 6 MeV external x-ray photon
beam, which targets a spherical inclusion, indicative of an external beam radiation therapy
(EBRT) treatment. For simplicity of the example, the beam was assumed mono-energetic,
although accurate simulation of a linear accelerator’s poly-energetic particle spectrum can be
accomplished by generating primaries from a phase space file. The time profile of the beam
was set such that all x-ray photons were generated at time t = 0 ns, analogous to an impulse
function. The geometry is shown in Figs. 6(a) and 6(b). As the x-ray photon beam enters the
tissue volume, secondary electrons are liberated within the medium, which subsequently
result in optical photon generation via the Čerenkov effect.
In the second scenario, shown in Figs. 6(c) and 6(d), optical photons are generated via a
radionuclide [in this case a positron-emitting tomography (PET) agent], 18F, which produces
Čerenkov photons during radioactive decay, primarily due to the propagation of the emitted
positrons.
In both cases, the geometry is the same and consists of: a 4 × 4 × 4 cm3 tissue volume
with the origin located at its center. A 1 cm radius spherical inclusion is placed with its center
located at (0, 0, 0.75) cm. In addition, a 0.1 cm radius, 4.0 cm length cylindrical vessel with
its center located at (−1.0, 0, 1.75) cm rotated 63.5 degrees in the x-y plane is placed in the
tissue volume. The main tissue volume contains an absorption coefficient, μa, and scattering
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coefficient, μs. The spherical inclusion contains a separate absorption coefficient, μa2, and the
same scattering coefficient. In addition, the spherical inclusion contains a fluorophore with
absorption coefficient, μaf, and emission spectrum If. The quantum yield of the fluorophore, φ,
was set to 1.0, and the time profile set to an exponential with a lifetime, t, of 0.1 ns. Finally,
the vessel absorption coefficient was set to μa3, and the same scattering coefficient as the
background and inclusion. For all three volumes, the refractive index was set to a spectrally
constant 1.41, and the anisotropy, g, was set to a spectrally constant 0.9. In all simulations
only the Mie scattering process was used. The simulated waveband was constrained to 550 –
850 nm, and the spectral characteristics of the defined attenuation coefficients are shown in
Fig. 7. Note two spectra for μa2 are shown, as the absorption coefficient of the inclusion was
simulated for a fully oxygenated and deoxygenated case.

Fig. 7. In (a) the spectral characteristics of the defined attenuation coefficients. The vessel
background absorption, μa2 is shown for the completed oxygenated and deoxygenated cases. In
(b) the fluorescence absorption and emission are shown.

To highlight the ability of the GEANT4/GAMOS tissue optics plug-in to simulate relevant
optical systems, the recorded data outputs were chosen such that an imaging and fiber based
system could be modeled and investigated. To facilitate both of these systems in a single
simulation, a phase plane was designated at the top surface of the tissue volume above the
vessel and inclusion. Each optical photon generated within the medium due to the Čerenkov
effect, emerging from the tissue volume, and traversing the phase plane was recorded and its
exiting position (x,y), direction (u,v,w), creator process (Čerenkov or fluorescence), and
wavelength were saved in CSV format. The data was then post-processed to yield the desired
outputs.
For the external radiation beam scenario, a single simulation of 107 incident x-ray photons
was performed and the SO2 = 100% μa2 was used. To generate the camera-based
measurements, the recorded optical photon histories were binned into 1 × 1 mm2 pixels for all
emerging photons regardless of exiting direction, (i.e, all were assumed to be captured by an
externally placed camera lens focused on the tissue surface). The resulting remission was
further normalized to the number of incident x-rays, i.e., the values displayed in the images is
in [captured optical photons mm−2 incident x-ray−1]. The resulting images for the total
collected light, as well as that created due to the Čerenkov effect, and that due to Čerenkovexcited fluorescence are shown in Fig. 8.
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Fig. 8. In (a) the total remitted light captured by an externally placed camera for the external
radiation beam scenario. In (b) and (c) the components of the remitted light due to the
Čerenkov effect and Čerenkov-excited fluorescence are shown. The white outlines denote the
locations of the vessel and inclusion.

In the case of the external radiation beam, Čerenkov light is generated in the horizontal
direction along the entire volume of the beam traversing the tissue volume, see Figs. 6(a) and
6(b). Less remitted light is seen within the first several millimeters due to the existence of a
buildup region where the number of secondary electrons generated by the incident x-ray
photons has not yet reached equilibrium due to their non-zero propagation distance. In
addition, the Čerenkov image appears brightest at the left side of the tissue volume due to the
forward dominance of x-ray, electron scattering and forward dominated optical photon
scattering, g = 0.9 for all volumes in the simulation, (i.e., optical photons generated to the
right side of the reflectance image continue to propagate to the left resulting in a buildup of
intensity). As expected, the fluorescence appears localized at the inclusion, and the absorbing
vessel shows up as an attenuating feature in the captured images.
Utilizing the wavelength information for each recorded photon, the data processing can be
taken a step further to mimic spectral imaging. To investigate the concept, the images were
further processed in wavelength using 20 nm binning between 550 – 850 nm. The resulting
images at three wavebands of interest, 550 – 570 nm, 690 – 710 nm, and 770 – 790 nm are
shown in Fig. 9. Between 550 – 570 nm, the remitted light is weakest due to the enhanced
absorption of the hemoglobin spectra, see μa2 and μa3 in Fig. 6. Spatially, the dark portions of
the images in this waveband also correspond with the locations of the vessel and inclusion.
Furthermore, as expected no remitted fluorescence is observed.
In the second waveband, between 690 – 710 nm, both the inclusion and vessel appear to
have little effect on the captured images. This is due to the minimal absorption of hemoglobin
in this waveband. Furthermore, in this waveband there exists no additional absorption due to
the fluorophore, and no fluorescence emission due to the fluorophore, see Fig. 6(b). Finally,
in the third waveband between 770 – 790 nm, the remitted fluorescence within the inclusion
can be clearly seen.
From the same simulation and recorded data, fiber based measurements were also
investigated. In order to investigate the ability of the fiber measurements to spectrally detect
changes in the oxygenation of the inclusion, an identical external radiation beam simulation
with the same data outputs was performed, in this case with the SO2 = 0% μa2. The three fiber
locations selected for analysis are shown in Fig. 10(a). The first location was chosen to be
above the vessel and inclusion, the second location centered on the inclusion, and the third
location symmetric to the first, but in this case not above the vessel.
In order to extract the appropriate subset of the total number of photons recorded in the
phase plane, the photons captured by any fiber were filtered based on location and direction.
For example, for the center fiber position, assuming a 1 mm diameter fiber with a numerical
aperture (NA), of 0.5 and refractive index, n, of 1.5, the position data was used to select only
photons with emerging positions of (x 2 + y 2 ) ≤ 0.5 mm, and directions of
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cos −1 (w ) ≤ sin −1 (NA / n ) where the photons exiting angle is calculated as cos(θ ) = w where

the photon directions are normalized such that u 2 + v 2 + w 2 = 1 .

Fig. 9. In (a-c) the captured reflectance images between 550 – 570 nm for an external radiation
beam incident on the tissue volume. In (d-f) and (g-i) reflectance images are shown between
690 – 710 nm, and 770 – 790 nm respectively.

The results for the three fiber position spectra are shown in Figs. 10(b)-10(d). In each plot,
the total collected spectra is shown by a solid line, and the spectral components from
Čerenkov and fluorescent light by the two dotted lines. In addition, all three lines are shown
for the oxygenated (red) and deoxygenated (blue) inclusion absorption coefficients.
At the first fiber position, Fig. 10(b) the spectral components due to the Čerenkov light
and excited fluorescence can be clearly seen. Due to the presence of the vessel, the
wavelengths below 650 nm are highly attenuated. At the second fiber position, Fig. 10(c), due
to its centering on the inclusion, twice the fluorescence intensity is observed. Finally, at the
third fiber position, Fig. 10(d), the spectra are nearly identical to that of the first position,
except the wavelengths below 650 nm are less attenuated due to the absence of the vessel.
More captured light is also observed in this waveband relative to the second position due to
its increased distance from the inclusion, which contains the additional fluorophore
absorption in this waveband.
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Fig. 10. In (a) the three chosen fiber locations are shown. In (b-d) the corresponding spectra
from the three positions are plotted. The solid lines denote the total collected light, and the two
dotted type lines the spectral components due to Čerenkov light and Čerenkov-excited
fluorescence. The oxygenated (red) and deoxygenated (blue) inclusion absorption coefficient
cases are also denoted.

Finally, to compare the Čerenkov light from an external radiation beam to that of the 18F
radionuclide, a single simulation was performed using 108 decay particles and the oxygenated
inclusion absorption coefficient, SO2 = 100% μa2. Note, an additional order of magnitude in
primary particles was simulated due to the less energetic charged particles produced by 18F
relative to the external radiation beam, and therefore fewer Čerenkov photons produced. For
comparative purposes, only the camera based white light images are shown in Fig. 11.
The difference in spatial characteristics can be clearly seen. In contrast to the external
radiation beam, the localization of the incident particles within the inclusion leads to
Čerenkov light and Čerenkov-excited fluorescence which are only localized within the
inclusion (i.e., no remitted light is visible to the left side of the images where the external
radiation beam Čerenkov light was peaked). Furthermore, due to the less energetic charged
particles produced by the radionuclide relative to the external radiation beam, the remitted
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light, in units of [captured optical photons mm−2 decay particle−1] is approximately an order of
magnitude weaker.

Fig. 11. In (a) the total remitted light captured by an externally placed camera for the PET
tracer scenario. In (b) and (c) the components of the remitted light due to the Čerenkov effect
and Čerenkov-excited fluorescence are shown. The white outlines denote the locations of the
vessel and inclusion.

4. Discussion
In this study we have presented and validated a tissue-optics software plug-in for the
GEANT4/GAMOS architecture that facilitates the simulation of radiation-induced light
transport in biological media. While the GEANT4/GAMOS package is a well-validated
simulation tool for high-energy particle transport through matter, to the best of the authors’
knowledge, this is the first study to rigorously validate the light transport in comparison to
accepted standards within the biomedical optics community. The results of validation
simulations performed in this study confirm the ability of the combined simulation package to
accurately calculate the total diffuse reflectance and transmittance for a refractive index
matched and mismatched boundary, as well as angularly, temporally, and spatially resolve the
characteristics of optical photon propagation in tissue.
With validated light transport mechanics, the tissue optics plug-in provides users with
access to a host of stochastic Monte Carlo (MC) modeling capabilities already included in the
GEANT4/GAMOS framework, (i.e., the ability to specify advanced source detector
distributions, generate complex heterogeneous geometries, and record a wide range of data
outputs). The resultant GEANT4/GAMOS tissue optics package therefore provides an
innovative tool to accurately simulate the measurement of Čerenkov-based optical photons
that originate from high-energy radiation propagation in biological media. The Čerenkov
process requires the coupled consideration of high-energy and optical photon transport (as
detailed in Fig. 1), a requirement that surpasses the capabilities of all standard MC light
transport packages that are currently publically available. The Čerenkov-based example
simulation presented in Section 3.2 demonstrates the capability of this novel package to
simulate broadband light propagation in a complex heterogeneous geometry with varying
optical properties induced by a detailed source specification (i.e., external radiation beam or
radionuclide of a given particle type, energy, positional, directional and temporal
distribution), with flexible data outputs (e.g., data recording location, and particle position,
direction, time, wavelength, and creation process). The implication of the data recording
flexibility is that a given optical system of interest can be easily simulated and investigated, or
multiple modalities can be simulated in a single simulation (i.e., camera and/or fiber
measurements).
The presented examples serve as demonstrations of the capabilities of the simulation
package, and are directly relevant to a number of already reported investigations into the
medical application of Čerenkov light. For example, fiber measurements of Čerenkov light
and/or fluorescence induced by an external radiation beam in tissue have been explored for
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oxygenation measurements and treatment monitoring during radiation therapy [10–13].
Furthermore, a number of studies have investigated the use of CLI to track radionuclides in
vivo using camera-based systems [3–6]. Therefore the envisioned use of this software is to
guide the design and development of optical devices used to collect Čerenkov-based optical
measurements. Future work in this area is likely to address light transport related pressing
questions for Čerenkov-based applications in tissue, including: optimization of detector
details (e.g. type, location, orientation), improving the understanding of the location of origin
of the collected photons during measurement, and characterizing influence of background
tissue optical properties and heterogeneities on the collected spectral signal. Furthermore,
although not detailed in the present study, radiation-induced light transport may also
encompass scintillation, the luminescence process analogous to fluorescence where the
absorbed energy is provided by a charged particle rather than photon. Similar to the Čerenkov
effect, applications of scintillation within the field of biomedical optics are in its infancy,
although a recent report has investigated the use of nano-scintillators as an internal excitation
source for photodynamic therapy (PDT) [41]. Therefore, the plug-in modified software
package described in the present paper may be of use in studying radiation-induced light
transport of scintillation photons for an emerging number of novel applications.
While the work presented within this paper focuses on the use of the GEANT4/GAMOS
tissue optics plug-in to simulate Čerenkov-based measurements, it is important to note the
core aspects of the package, which makes this a unique investigative tool that can be extended
to multiple areas within the field of biomedical optics. A brief list of important advantages
include: (1) The specification of optical detectors at multiple (co-registered) locations that are
capable of scoring photon tissue interactions from an extensive catalogue within the GAMOS
framework (e.g., detectors can return interaction type, frequency, and location for collected
photons); this represents an advantage over standard MC codes which may require
reprogramming to perform non-standard interaction/event tracking or specification of
multiple co-registered detectors. (2) Broadband simulation capabilities allow for userspecification of wavelength-dependent optical properties and model estimation of spectral
response; this capability avoids the need to either initialize independent simulations at
multiple wavelengths or apply perturbation scaling factors which may limit the range of
scattering properties within a spectrum that can be accurately investigated [42,43].
Furthermore, the ability to sample photon generation in a fixed or continuous manner has
been provided to allow users to control the spectral resolution of such simulations. (3) A
geometry can be constructed using a combination of standard shapes (i.e., polygons,
ellipsoids, cylinders, etc.) to yield heterogeneous volumes containing layers and/or inclusions,
each of which may contain user-specified optical properties. (4) A user-defined wavelengthdependent scattering phase function can be defined, providing users with a unique framework
for investigating phase functions beyond the more conventional Henyey-Greenstein
approximation. Furthermore, in complex heterogeneous geometries, a separate user-defined
phase function can be defined in each material, a new feature added by the tissue optics plugin.
While these listed advantages are not necessarily unique in functionality compared with
previously reported custom MC packages, the robust catalogue of user-defined inputs and
outputs within the GAMOS interface allows users to adjust these simulation parameters
without requiring C or C++ level programming. Furthermore, the presented plug-in and core
simulation software is fully open-source and publically available unlike many modified inhouse MC codes that have previously reported to achieve some of the functionality described
in the present study. Despite its robust features, the GEANT4/GAMOS tissue optics package
is not well-suited for all simulation purposes, as it does not offer GPU-based acceleration or
mesh-based grid generation, options that limit the efficiency and accuracy in complex media.
However, increased efficiency represents the goal of a future study, as the plug-in modified
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simulation package described herein represents the only current validated architecture capable
of simulating both the high-energy radiation and subsequent diffuse light transport.
The plug-in, user guide, example files, as well as the necessary files to reproduce the
validation simulations are available at http://www.dartmouth.edu/optmed/researchprojects/monte-carlo-software.
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